Radiomics in esophageal and gastric cancer Article Swipe
Related Concepts
Medicine
Esophageal cancer
Hepatology
Cancer
Internal medicine
Quality of life (healthcare)
Radiomics
Oncology
Intensive care medicine
Gastroenterology
General surgery
Radiology
Nursing
Bert-Ram Sah
,
Kasia Owczarczyk
,
Musib Siddique
,
Gary Cook
,
Vicky Goh
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1007/s00261-018-1724-8
· OA: W2886231601
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1007/s00261-018-1724-8
· OA: W2886231601
Esophageal, esophago-gastric, and gastric cancers are major causes of cancer morbidity and cancer death. For patients with potentially resectable disease, multi-modality treatment is recommended as it provides the best chance of survival. However, quality of life may be adversely affected by therapy, and with a wide variation in outcome despite multi-modality therapy, there is a clear need to improve patient stratification. Radiomic approaches provide an opportunity to improve tumor phenotyping. In this review we assess the evidence to date and discuss how these approaches could improve outcome in esophageal, esophago-gastric, and gastric cancer.
Related Topics
Finding more related topics…